<DOC>
	<DOCNO>NCT02359201</DOCNO>
	<brief_summary>The purpose study evaluate reduction crave administration V0018 1.5 mg compare placebo healthy moderately dependent smoker .</brief_summary>
	<brief_title>Assessment V0018 1.5 mg Effect Craving</brief_title>
	<detailed_description />
	<mesh_term>Nicotine</mesh_term>
	<criteria>Male female age 18 64 year Smoking â‰¥ 10 cigarettes/day &lt; 20 cigarettes/day continuously last two year With first cigarette smoke within 30 min wake Not currently process quit smoking Related pathology Current recurrent buccal lesion , opinion investigator , would interfere assessment different parameter Hyposalivation asialia Intolerance lactose , pathology could cause endogenous production Carbon Monoxide ( CO ) Related treatment Use antidepressant within last three month Use sedative , hypnotic , tranquilizer addictive agent within last 3 month Routine use tobacco cigarette Regular use one week treatment smoke cessation ( gum , patch , inhaler , lozenge , tablet , bupropion , varenicline ) smokeless tobacco product ( include ecigarettes ) within three month History hypersensitivity nicotine , peanut , soya excipients study treatment Intolerance fructose History phenylketonuria ( aspartame ) For woman childbearing potential : Is pregnant postpartum period nursing mother</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Nicotine replacement therapy</keyword>
	<keyword>crave</keyword>
	<keyword>Healthy moderately dependant smoker</keyword>
</DOC>